Literature DB >> 29140818

Drop instillation and glaucoma.

Scott A Davis1, Betsy Sleath1,2, Delesha M Carpenter1, Susan J Blalock1, Kelly W Muir3, Donald L Budenz4.   

Abstract

PURPOSE OF REVIEW: To describe the current state of knowledge regarding glaucoma patients' eye drop technique, interventions attempting to improve eye drop technique, and methods for assessing eye drop technique. RECENT
FINDINGS: In observational studies, between 18.2 and 80% of patients contaminate their eye drop bottle by touching their eye or face, 11.3-60.6% do not instill exactly one drop, and 6.8-37.3% miss the eye with the drop. Factors significantly associated with poorer technique include older age, lack of instruction on eye drop technique, female sex, arthritis, more severe visual field defect, lack of positive reinforcement to take eye drops, lower educational level, low self-efficacy, and being seen at a clinic rather than a private practice. Among intervention studies, four of five studies using a mechanical device and three of four studies using educational interventions to improve technique showed positive results, but none of the studies were randomized controlled trials.
SUMMARY: Poor eye drop technique is a significant impediment to achieving good control of intraocular pressure in glaucoma. Both mechanical device interventions and educational interventions offer promise to improve patients' technique, but studies with stronger designs need to be done followed by introduction into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29140818      PMCID: PMC6422028          DOI: 10.1097/ICU.0000000000000451

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

Review 1.  Evolution of drug-eluting biomedical implants for sustained drug delivery.

Authors:  Juliana C Quarterman; Sean M Geary; Aliasger K Salem
Journal:  Eur J Pharm Biopharm       Date:  2020-12-16       Impact factor: 5.589

2.  Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose.

Authors:  Louis R Pasquale; Shan Lin; Robert N Weinreb; James C Tsai; Robert L Kramm; Tsontcho Ianchulev
Journal:  Clin Ophthalmol       Date:  2018-11-28

3.  Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya - A Pilot Study.

Authors:  Ian Murdoch; David Nyakundi; Helen Baker; Simon Dulku; Daniel Kiage
Journal:  Patient Prefer Adherence       Date:  2020-02-10       Impact factor: 2.711

4.  Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies.

Authors:  Hugo Quiroz-Mercado; Ehud Ivri; Roberto Gonzalez-Salinas; Iraklis C Kourtis; Joseph Gilbert; José Francisco Pérez-Vázquez; Mark Blumenkranz; Jesús Jiménez-Román; George Marcellino
Journal:  Clin Ophthalmol       Date:  2020-01-20

5.  Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery.

Authors:  Mahmoud A Khaimi
Journal:  Ther Adv Ophthalmol       Date:  2021-09-27

6.  Knowledge, Attitudes, and Practices Toward Self-Medicating Eye Symptoms in Saudi Arabia.

Authors:  Dalal Ibrahim Alessa; Reem Rashed AlHuthail; Shahd Abdullah Al Mahfud; Ayshah Sayed Alshngeetee; Shahad A Alruwaili; Ahmad Mamoun Khalaf; Malak Mohammed Almutlq
Journal:  Clin Ophthalmol       Date:  2022-03-10

7.  Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy.

Authors:  Kevin J Schneider; Cecilia N Hollenhorst; Autumn N Valicevic; Leslie M Niziol; Michele Heisler; David C Musch; Stephen M Cain; Paula-Anne Newman-Casey
Journal:  Ophthalmol Glaucoma       Date:  2020-08-08

Review 8.  Therapeutic Contact Lenses with Polymeric Vehicles for Ocular Drug Delivery: A Review.

Authors:  Seung Woo Choi; Jaeyun Kim
Journal:  Materials (Basel)       Date:  2018-07-01       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.